Mediclinic is committed to maintaining strict principles of good corporate governance and the highest standards of integrity and ethics. The Board accepts full responsibility for corporate governance and is committed to ensuring a high standard of discipline, independence, ethics, equity, social responsibility, accountability, cooperation and transparency. The Board is satisfied that the Company meets the requirements of the Companies Act, the Listings Requirements of the JSE Limited ("the JSE") and the majority of the principles contained in the King Report on Governance for South Africa ("King III"). All the King III principles which the Company has not applied are explained, where applicable, in the latest annual report, also stating for what part of the year any non-compliance had occurred. An index on the application of each King III principle is published on the Investor Relations section of our website with the integrated annual report. 

A Group Corporate Governance Manual dealing with board practices and group policies provides guidance to the Company Secretary and the Board of the Company, as well as the company secretaries, boards and management of the Company's three operating platforms in Southern Africa, Switzerland and the United Arab Emirates to ensure that similar corporate governance practices are followed throughout the Group. The Group Company Secretary also provides continuous guidance on corporate governance related matters to the operating platforms.

Compliance with all relevant laws, regulations, accepted standards or codes is integral to the Group's risk management process and is monitored.